XML 41 R29.htm IDEA: XBRL DOCUMENT v3.20.2

Revenue Recognition - Disaggregated Sales Analysis (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Disaggregation of Revenue [Line Items]
Net sales	$ 3,737	$ 3,587	$ 10,089	$ 10,753
United States
Disaggregation of Revenue [Line Items]
Net sales	2,748	2,644	7,357	7,918
International
Disaggregation of Revenue [Line Items]
Net sales	989	943	2,732	2,835
Orthopaedics
Disaggregation of Revenue [Line Items]
Net sales	1,317	1,262	3,433	3,785
Orthopaedics | United States
Disaggregation of Revenue [Line Items]
Net sales	937	872	2,412	2,596
Orthopaedics | International
Disaggregation of Revenue [Line Items]
Net sales	380	390	1,021	1,189
Orthopaedics | Knees
Disaggregation of Revenue [Line Items]
Net sales	435	426	1,108	1,305
Orthopaedics | Knees | United States
Disaggregation of Revenue [Line Items]
Net sales	332	318	833	962
Orthopaedics | Knees | International
Disaggregation of Revenue [Line Items]
Net sales	103	108	275	343
Orthopaedics | Hips
Disaggregation of Revenue [Line Items]
Net sales	334	332	866	1,011
Orthopaedics | Hips | United States
Disaggregation of Revenue [Line Items]
Net sales	223	211	564	643
Orthopaedics | Hips | International
Disaggregation of Revenue [Line Items]
Net sales	111	121	302	368
Orthopaedics | Trauma and Extremities
Disaggregation of Revenue [Line Items]
Net sales	430	407	1,152	1,197
Orthopaedics | Trauma and Extremities | United States
Disaggregation of Revenue [Line Items]
Net sales	285	262	753	768
Orthopaedics | Trauma and Extremities | International
Disaggregation of Revenue [Line Items]
Net sales	145	145	399	429
Orthopaedics | Other
Disaggregation of Revenue [Line Items]
Net sales	118	97	307	272
Orthopaedics | Other | United States
Disaggregation of Revenue [Line Items]
Net sales	97	81	262	223
Orthopaedics | Other | International
Disaggregation of Revenue [Line Items]
Net sales	21	16	45	49
MedSurg
Disaggregation of Revenue [Line Items]
Net sales	1,600	1,552	4,546	4,680
MedSurg | United States
Disaggregation of Revenue [Line Items]
Net sales	1,269	1,247	3,567	3,755
MedSurg | International
Disaggregation of Revenue [Line Items]
Net sales	331	305	979	925
MedSurg | Instruments
Disaggregation of Revenue [Line Items]
Net sales	467	452	1,308	1,417
MedSurg | Instruments | United States
Disaggregation of Revenue [Line Items]
Net sales	369	357	1,028	1,121
MedSurg | Instruments | International
Disaggregation of Revenue [Line Items]
Net sales	98	95	280	296
MedSurg | Endoscopy
Disaggregation of Revenue [Line Items]
Net sales	467	474	1,238	1,424
MedSurg | Endoscopy | United States
Disaggregation of Revenue [Line Items]
Net sales	380	377	997	1,136
MedSurg | Endoscopy | International
Disaggregation of Revenue [Line Items]
Net sales	87	97	241	288
MedSurg | Medical
Disaggregation of Revenue [Line Items]
Net sales	600	554	1,819	1,627
MedSurg | Medical | United States
Disaggregation of Revenue [Line Items]
Net sales	455	442	1,363	1,288
MedSurg | Medical | International
Disaggregation of Revenue [Line Items]
Net sales	145	112	456	339
MedSurg | Sustainability
Disaggregation of Revenue [Line Items]
Net sales	66	72	181	212
MedSurg | Sustainability | United States
Disaggregation of Revenue [Line Items]
Net sales	65	71	179	210
MedSurg | Sustainability | International
Disaggregation of Revenue [Line Items]
Net sales	1	1	2	2
Neurotechnology and Spine
Disaggregation of Revenue [Line Items]
Net sales	820	773	2,110	2,288
Neurotechnology and Spine | United States
Disaggregation of Revenue [Line Items]
Net sales	542	525	1,378	1,567
Neurotechnology and Spine | International
Disaggregation of Revenue [Line Items]
Net sales	278	248	732	721
Neurotechnology and Spine | Neurotechnology
Disaggregation of Revenue [Line Items]
Net sales	518	490	1,370	1,443
Neurotechnology and Spine | Neurotechnology | United States
Disaggregation of Revenue [Line Items]
Net sales	323	316	835	929
Neurotechnology and Spine | Neurotechnology | International
Disaggregation of Revenue [Line Items]
Net sales	195	174	535	514
Neurotechnology and Spine | Spine
Disaggregation of Revenue [Line Items]
Net sales	302	283	740	845
Neurotechnology and Spine | Spine | United States
Disaggregation of Revenue [Line Items]
Net sales	219	209	543	638
Neurotechnology and Spine | Spine | International
Disaggregation of Revenue [Line Items]
Net sales	$ 83	$ 74	$ 197	$ 207

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(1))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

+ Details

Name:	us-gaap_Revenues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Details

Name:	srt_StatementGeographicalAxis=country_US
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_StatementGeographicalAxis=us-gaap_NonUsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=syk_KneesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=syk_HipsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=syk_TraumaandExtremitiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=syk_OtherOrthopaedicsDomain
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=syk_MedsurgMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=syk_InstrumentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=syk_EndoscopyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=syk_MedicalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=syk_SustainabilityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=syk_NeurotechnologyAndSpineMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=syk_NeurotechnologyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=syk_SpineMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: